THE GLP-1 MICRODOSING PROGRAM
- Regular price
-
$179 - Regular price
-
- Sale price
-
$179
GLP-1 Microdosing Program
Pricing is for a 28-day supply. Prescription medication. Medical evaluation required.
MICRODOSING SEMAGLUTIDE - $179
MICRODOSING TIRZEPATIDE - $269
*PLEASE NOTE: Microdosing program is available at an already discounted rate and is not available for any additional discounts.
Gentle support for mindful eating & metabolic wellness
The Fitish RX GLP-1 Microdosing Program is designed for individuals who are not looking for significant weight loss or maintenance dosing, but want subtle, cosmetic support to help reinforce balanced habits and mindful eating.
This program uses very low, carefully dosed GLP-1 medication to support metabolic wellness over time without the appetite suppression or intensity associated with traditional GLP-1 weight loss protocols.
What This Program Is
• Gentle GLP-1 support at micro doses
• Designed for cosmetic weight support, not scale-driven results
• Helps reinforce mindful eating and portion awareness
• Focused on metabolic wellness over time
Who This Is Best For
This program may be a fit if you:
• Want light support with food noise or portion awareness
• Are focused on wellness, balance, and long-term habits
• Are not seeking aggressive appetite suppression
• Want a gentler entry point into GLP-1 support
Why Microdosing?
Microdosing allows for:
• Lower overall medication exposure
• Reduced risk of side effects
• Subtle support that works with your habits, not against them
• A more mindful, wellness-forward approach to GLP-1 use
This program is about supporting consistency, not forcing outcomes.
Learn more: read our full guides to microdosing tirzepatide and microdosing semaglutide, or compare them in the GLP-1 microdosing chart.
What This Program Is NOT
• Not a weight loss program
• Not a maintenance program
• Not designed for rapid or significant weight reduction
• Not intended to replace lifestyle habits
Please note: The Microdosing Program is offered only at a fixed, low starting dose and does not increase over time. For higher or adjustable dosing options, please refer to our standard GLP-1 program.
Important Program Disclaimer
The Fitish RX GLP-1 Microdosing Program is intended for general wellness and cosmetic support only and is not a weight loss or weight management program. Individual results may vary. This program is not designed to diagnose, treat, cure, or prevent any medical condition. All medications are prescribed based on an individual clinical evaluation by a licensed medical provider. Participation in this program does not replace healthy lifestyle habits, including balanced nutrition and regular movement. Always follow your provider’s guidance and reach out with any questions or concerns.
More
Tirzepatide is a GLP-1 and GIP receptor agonist medication; semaglutide is a GLP-1 receptor agonist medication. Compounded tirzepatide and compounded semaglutide are custom-prepared by a state-licensed compounding pharmacy based on a prescription from a licensed provider. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. State-licensed compounding pharmacies follow both federal and state regulations, including quality standards.
Safety Details
Compounded Semaglutide (Injection)
BLACK BOX WARNING: RISK OF THYROID C-CELL TUMORS
Semaglutide may cause serious side effects, including possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Semaglutide and medicines that work like Semaglutide caused thyroid tumors, including thyroid cancer. It is not known if Semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
ABOUT COMPOUNDED MEDICATIONS
Compounded semaglutide is prepared by a state licensed sterile compounding pharmacy and is prescribed where clinically appropriate based on your medical evaluation. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Your provider determines your dose based on your medical evaluation. FDA-approved medicines containing semaglutide are commercially available.
Do not use Semaglutide if:
You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
You have had a serious allergic reaction to semaglutide or any of the ingredients in Semaglutide.
Before using Semaglutide, tell your healthcare provider if you have any other medical conditions, including if you:
Have or have had problems with your pancreas or kidneys.
Have type 2 diabetes and a history of diabetic retinopathy.
Have or have had depression, suicidal thoughts, or mental health issues.
Are pregnant or plan to become pregnant. Semaglutide may harm your unborn baby. You should stop using Semaglutide 2 months before you plan to conceive.
Are breastfeeding or plan to breastfeed. It is not known if Semaglutide passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Semaglutide may affect the way some medicines work and some medicines may affect the way Semaglutide works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Semaglutide slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
What are the possible side effects of Semaglutide?
Semaglutide may cause serious side effects, including:
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Inflammation of your pancreas (pancreatitis): Stop using Semaglutide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
Gallbladder problems: Semaglutide may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin: This can be both a serious and common side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Semaglutide. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery.
Kidney problems (kidney failure): In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
Serious allergic reactions: Stop using Semaglutide and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Change in vision in people with type 2 diabetes: Tell your healthcare provider if you have changes in vision during treatment with Semaglutide.
Increased heart rate: Semaglutide can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes.
Depression or thoughts of suicide: You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.
The most common side effects of Semaglutide may include:
Nausea
Diarrhea
Vomiting
Constipation
Stomach (Abdomen) Pain
Headache
Tiredness (Fatigue)
Upset Stomach
Dizziness
Feeling Bloated
Belching
Gas
Stomach Flu
Heartburn
Runny Nose
Sore Throat
Semaglutide is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit https://www.fda.gov/medwatch or call 1800FDA1088.
This summary provides basic information about compounded semaglutide but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about compounded semaglutide and how to take it. Your healthcare provider is the best person to help you decide if compounded semaglutide is right for you.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information.
Compounded Tirzepatide (Injection)
BLACK BOX WARNING: RISK OF THYROID C-CELL TUMORS
Tirzepatide may cause serious side effects, including possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Tirzepatide and medicines that work like Tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if Tirzepatide will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
ABOUT COMPOUNDED MEDICATIONS
Compounded tirzepatide is prepared by a state licensed sterile compounding pharmacy and is prescribed where clinically appropriate based on your medical evaluation. Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Your provider determines your dose based on your medical evaluation. FDA-approved medicines containing tirzepatide are commercially available.
Do not use Tirzepatide if:
You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
You have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tirzepatide may cause serious side effects, including:
Inflammation of the pancreas (pancreatitis): Stop using Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
Low blood sugar (hypoglycemia): Your risk for getting low blood sugar may be higher if you use Tirzepatide with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
Serious allergic reactions: Stop using Tirzepatide and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
Kidney problems (kidney failure): In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
Severe stomach problems: Stomach problems, sometimes severe, have been reported in people who use Tirzepatide. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
Changes in vision: Tell your healthcare provider if you have changes in vision during treatment with Tirzepatide.
Gallbladder problems: Gallbladder problems have happened in some people who use Tirzepatide. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.
SIDE EFFECTS
Many people experience no side effects. Some of the most common or potential side effects of Tirzepatide include:
Nausea
Diarrhea
Decreased Appetite
Vomiting
Constipation
Indigestion
Stomach (Abdominal) Pain
These are not all the possible side effects of Tirzepatide. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.
DRUG INTERACTIONS
As with other medications, compounded Tirzepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Tirzepatide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Tirzepatide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (i.e., warfarin) should be monitored closely while on Tirzepatide.
This summary provides basic information about compounded Tirzepatide but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about compounded Tirzepatide and how to take it. Your healthcare provider is the best person to help you decide if compounded Tirzepatide is right for you.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information.
You are encouraged to report negative side effects of compounded tirzepatide to the FDA. Visit https://www.fda.gov/medwatch or call 1800FDA1088. In case of emergencies, please call 911 or go to the nearest emergency room.




